Evidence map›Paper›PMID 38321033›Full record

ArticleCell death discovery2024

Dependence of human cell survival and proliferation on the CASP3 prodomain.

Ebrahim Eskandari, Gian Luca Negri, Susanna Tan, Margarita E MacAldaz, Shengsen Ding, Justin Long, Karina Nielsen, Sandra E Spencer, Gregg B Morin, Connie J Eaves

Abstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chemical Composition and Anti-Lung Cancer Activities ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  9. Transient Upregulation of Procaspase-3 during Oligodendrocyte Fate Decisions.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ebrahim EskandariTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Gian Luca NegriCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-7722-8888
Susanna TanTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Margarita E MacAldazTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Shengsen DingTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Justin LongTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
Karina NielsenCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
Sandra E SpencerCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada.
Gregg B MorinDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-8949-4374
Connie J EavesTerry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada. ceaves@bccrc.ca.ORCID http://orcid.org/0000-0002-3452-1926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanisms that regulate cell survival and proliferation are important for both the development and homeostasis of normal tissue, and as well as for the emergence and expansion of malignant cell populations. Caspase-3 (CASP3) has long been recognized for its proteolytic role in orchestrating cell death-initiated pathways and related processes; however, whether CASP3 has other functions in mammalian cells that do not depend on its known catalytic activity have remained unknown. To investigate this possibility, we examined the biological and molecular consequences of reducing CASP3 levels in normal and transformed human cells using lentiviral-mediated short hairpin-based knockdown experiments in combination with approaches designed to test the potential rescue capability of different components of the CASP3 protein. The results showed that a ≥50% reduction in CASP3 levels rapidly and consistently arrested cell cycle progression and survival in all cell types tested. Mass spectrometry-based proteomic analyses and more specific flow cytometric measurements strongly implicated CASP3 as playing an essential role in regulating intracellular protein aggregate clearance. Intriguingly, the rescue experiments utilizing different forms of the CASP3 protein showed its prosurvival function and effective removal of protein aggregates did not require its well-known catalytic capability, and pinpointed the N-terminal prodomain of CASP3 as the exclusive component needed in a diversity of human cell types. These findings identify a new mechanism that regulates human cell survival and proliferation and thus expands the complexity of how these processes can be controlled. The graphical abstract illustrates the critical role of CASP3 for sustained proliferation and survival of human cells through the clearance of protein aggregates.

Identifiers

PMID38321033
PMCPMC10847432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.